These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 2159464

  • 1. Functional receptors for transforming growth factor-beta are retained by biochemically differentiated C2 myocytes in growth factor-deficient medium containing EGTA but down-regulated during terminal differentiation.
    Hu JS, Olson EN.
    J Biol Chem; 1990 May 15; 265(14):7914-9. PubMed ID: 2159464
    [Abstract] [Full Text] [Related]

  • 2. Regulation of differentiation of the BC3H1 muscle cell line through cAMP-dependent and -independent pathways.
    Hu JS, Olson EN.
    J Biol Chem; 1988 Dec 25; 263(36):19670-7. PubMed ID: 2461941
    [Abstract] [Full Text] [Related]

  • 3. Interruption of myogenesis by transforming growth factor beta 1 or EGTA inhibits expression and activity of the myogenic-associated (2'-5') oligoadenylate synthetase and PKR.
    Salzberg S, Mandelboim M, Zalcberg M, Shainberg A.
    Exp Cell Res; 1995 Jul 25; 219(1):223-32. PubMed ID: 7628537
    [Abstract] [Full Text] [Related]

  • 4. Regulation of myogenic differentiation by type beta transforming growth factor.
    Olson EN, Sternberg E, Hu JS, Spizz G, Wilcox C.
    J Cell Biol; 1986 Nov 25; 103(5):1799-805. PubMed ID: 3465734
    [Abstract] [Full Text] [Related]

  • 5. Type beta transforming growth factor is an inhibitor of myogenic differentiation.
    Massagué J, Cheifetz S, Endo T, Nadal-Ginard B.
    Proc Natl Acad Sci U S A; 1986 Nov 25; 83(21):8206-10. PubMed ID: 3022285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential effects of fibroblast growth factor on insulin receptor and muscle specific protein gene expression in BC3H-1 myocytes.
    Brunetti A, Goldfine ID.
    Mol Endocrinol; 1990 Jun 25; 4(6):880-5. PubMed ID: 2172794
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biological effects and binding properties of transforming growth factor-beta on human oral squamous cell carcinoma cells.
    Ichijo H, Momose F, Miyazono K.
    Exp Cell Res; 1990 Apr 25; 187(2):263-9. PubMed ID: 2156718
    [Abstract] [Full Text] [Related]

  • 16. Ca2+ and Na+ currents in developing skeletal myoblasts are expressed in a sequential program: reversible suppression by transforming growth factor beta-1, an inhibitor of the myogenic pathway.
    Caffrey JM, Brown AM, Schneider MD.
    J Neurosci; 1989 Oct 25; 9(10):3443-53. PubMed ID: 2552033
    [Abstract] [Full Text] [Related]

  • 17. Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2.
    Chakrabarty S, Fan D, Varani J.
    Int J Cancer; 1990 Sep 15; 46(3):493-9. PubMed ID: 1697568
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transforming growth factor-beta isoform expression in insulin-like growth factor stimulated myogenesis.
    Bosche WJ, Ewton DZ, Florini JR.
    J Cell Physiol; 1995 Aug 15; 164(2):324-33. PubMed ID: 7542663
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.